Back
Eli Lilly & Co. Vs. Regeneron Pharmaceuticals, Inc. Sector Stock Comparison
Buy
79
LLY
Eli Lilly & Co.
Last Price:
$1,080.42
Seasonality Move:
2.33%
Buy
62
REGN
Regeneron Pharmaceuticals, Inc.
Last Price:
$776.38
Seasonality Move:
3.83%
Buy
79
Eli Lilly & Co. (LLY)
is a Buy
Is Eli Lilly & Co. a Buy, Sell or Hold?
-
The current Eli Lilly & Co. [LLY] share price is $1,080.36. The Score for LLY is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
-
LLY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Regeneron Pharmaceuticals, Inc. (REGN)
is a Buy
Is Regeneron Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Regeneron Pharmaceuticals, Inc. [REGN] share price is $776.31. The Score for REGN is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
REGN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LLY Stock Price Chart
What is Eli Lilly & Co.'s stock price today?
-
The Eli Lilly & Co. share price today is $1,080.36Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LLY is experiencing buying pressure, which is a positive indicator for future bullish movement.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals, Inc.'s stock price today?
-
The Regeneron Pharmaceuticals, Inc. share price today is $776.31Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
LLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 22.59 | Buy |
| Relative Strength Index (14 RSI): | 64.06 | Buy |
| Chaikin Money Flow: | 2417262 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1017.9 - 1082.54) | Buy |
| Bollinger Bands (100): | (737.83 - 1017.75) | Buy |
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 209.77 | Buy |
| Relative Strength Index (14 RSI): | 62.46 | Buy |
| Chaikin Money Flow: | 236070 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (726.54 - 780.12) | Buy |
| Bollinger Bands (100): | (562.3 - 724.18) | Buy |
LLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1077.05 | Buy |
| 20-day SMA: | 1046.91 | Buy |
| 50-day SMA: | 997.57 | Buy |
| 200-day SMA: | 828.06 | Buy |
| 8-day EMA: | 1073.59 | Buy |
| 20-day EMA: | 1055.93 | Buy |
| 50-day EMA: | 998.02 | Buy |
| 200-day EMA: | 869.56 | Buy |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 779.48 | Sell |
| 20-day SMA: | 752.63 | Buy |
| 50-day SMA: | 711.25 | Buy |
| 200-day SMA: | 604.33 | Buy |
| 8-day EMA: | 727.11 | Buy |
| 20-day EMA: | 517.1 | Buy |
| 50-day EMA: | 275.46 | Buy |
| 200-day EMA: | 80.54 | Buy |
Eli Lilly & Co. Earnings Growth & LLY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.98 per share, and an increase next year of $7.48 per share.
Regeneron Pharmaceuticals, Inc. Earnings Growth & REGN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.81 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.14 per share, and an increase next year of $8.53 per share.
Eli Lilly & Co. Technical Analysis
| Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regeneron Pharmaceuticals, Inc. Technical Analysis
| Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||